Literature DB >> 2903334

Microbiological look at urodynamic studies.

S R Payne1, A G Timoney, S T McKenning, D den Hollander, L J Pead, R M Maskell.   

Abstract

Urine samples were cultured for aerobic, fastidious, and anaerobic bacteria in 88 patients (66 F, 22 M) before and after standard urodynamic investigations. 37 of 42 women with detrusor instability, and 14 of 17 women with stress incontinence, had evidence of bacteriuria with aerobic or fastidious bacteria before investigation, as did 6 of 13 men with bladder outflow obstruction. 8 men (36%) acquired bacteriuria with aerobic bacteria after investigation, compared with 10 women (15%). Recalcitrant, irritative urinary symptoms in women may be caused by an underlying infection, the urodynamic changes being secondary. In men who have urodynamic studies, antibiotic prophylaxis should be considered.

Entities:  

Mesh:

Year:  1988        PMID: 2903334     DOI: 10.1016/s0140-6736(88)90534-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Psychiatric aspects of urinary incontinence.

Authors:  R Maskell
Journal:  BMJ       Date:  1990-09-15

2.  The mysterious "urethral syndrome".

Authors: 
Journal:  BMJ       Date:  1991-08-10

Review 3.  Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder.

Authors:  C F Heyns
Journal:  World J Urol       Date:  2011-07-01       Impact factor: 4.226

4.  The usefulness of antibiotic prophylaxis in invasive urodynamics in postmenopausal female subjects.

Authors:  Salvatore Siracusano; Roberto Knez; Anna Tiberio; Vito Alfano; Antonella Giannantoni; Giovanni Pappagallo
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-02-22

5.  Prophylactic Antibiotics for Urinary Tract Infections after Urodynamic Studies: A Meta-Analysis.

Authors:  Xiao-Yu Wu; Yu Cheng; Sheng-Fei Xu; Qing Ling; Xiao-Yi Yuan; Guang-Hui Du
Journal:  Biomed Res Int       Date:  2021-02-28       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.